Evidence map›Paper›PMID 27011622›Full record

ReviewAnnals of Indian Academy of Neurology

Research in Parkinson's disease in India: A review.

Pratibha Surathi, Ketan Jhunjhunwala, Ravi Yadav, Pramod Kumar Pal

Open access · diamondAbstract readReview
In one paragraph

Review in Annals of Indian Academy of Neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. TRPA1 Role in Inflammatory Disorders: What Is Known So Far?International journal of molecular sciences · 2022
    Review
  11. Perceptions and meanings of living with Parkinson's disease: an account of caregivers lived experiences.International journal of qualitative studies on health and well-being · 2021
    Article
  12. Article
  13. Critical review of theBulletin of the National Research Centre · 2021
    Review
  14. 3 Biotech · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Pratibha SurathiDepartment of Neurology, National Institute of Mental Health and Neurosciences, Hosur Road, Bangalore, Karnataka, India.
Ketan JhunjhunwalaDepartment of Neurology, National Institute of Mental Health and Neurosciences, Hosur Road, Bangalore, Karnataka, India.
Ravi YadavDepartment of Neurology, National Institute of Mental Health and Neurosciences, Hosur Road, Bangalore, Karnataka, India.
Pramod Kumar PalDepartment of Neurology, National Institute of Mental Health and Neurosciences, Hosur Road, Bangalore, Karnataka, India.
National Institute of Mental Health and Neurosciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder affecting patients in large numbers throughout the world. In this article, we review all the published data on PD based on studies in Indian population. We have tried to consolidate the contribution of Indian studies in PD research. We found 95 articles, of which 92 were original research papers. This is a relatively less number, but in the last decade, there has been an increase in research on PD from this country. But most of them seem to be restricted to only a few research institutes. The nonmotor symptoms and genetics are the most commonly studied aspects. The systematic review of the articles reveals that the epidemiology in India may be different with relatively lesser incidence here. Most of the genetic mutations found to cause PD in other population are not found in India, revealing that other genetic factors may be involved. Further research needs to be encouraged to understand the disease in Indian patients better, as all the results cannot be extrapolated from the Western literature to this heterogeneous Indian population. There need to be more studies on therapeutic aspects of the disease.

Indexed as

EpidemiologygeneticsIndiaParkinson's diseasetreatment

Identifiers

PMID27011622
PMCPMC4782561
OpenAlexW2258473744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.